TCH (6 cycles every 3 weeks) vs Taxol (12 cycles every week)

I've had both treatments. Taxol, by far, is more easily tolerated but does require a weekly investment of time. Taxotere (TCH), every three weeks worked really well for me with my stage II Dx, I was able to work but was down for four days after a treatment so I did miss some work. When I was Dx'd stage IV ( 18 mos later), I started on Taxotere (Herceptin and Perjeta no Carboplatin) and it was much more difficult, I'm not certain if the Perjeta made the difference, or my age, or just the fact that I was doing chemo again but it became so difficult that I was no longer able to work and eventually had to give up treatment and switch over to Taxol weekly. I am doing a great deal better on Taxol but still not back to work. As far as one working better than the other, I don't believe there is evidence to support the benefit of either drug over the other.

sid - here is some info on Taxol and Herceptin for smaller Her2+ tumors:

http://www.breastcancer.org/research-news/20140207-4

http://www.ascopost.com/News/10846

http://www.cancertherapyadvisor.com/breast-cancer/breast-cancer-paclitaxel-trastuzumab-new-standard-care-treatment/article/401681/

Taxotere is a higher dose taxane, and when combined with Carboplatin can be more debilitating than a single agent regimen.  For node negative tumors, with a 1cm size or less, the more recent trend seems to be Taxol/Herceptin.